Tomoharu Ohkawara
Yahaba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure.
Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure.
Journal: The journal of allergy and clinical immunology. Global
Published: November 02, 2023
Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis.
Journal: Modern rheumatology
Published: October 12, 2023
A Role for Leucine-Rich α2-Glycoprotein in Leukocyte Trafficking and Mucosal Inflammation in Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: March 26, 2023
Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Journal: International journal of cancer
Published: October 19, 2022
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer.
Journal: Neoplasia (New York, N.Y.)
Published: June 08, 2022
SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.
Journal: Anticancer research
Published: May 12, 2022
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.
Journal: Oncotarget
Published: October 22, 2021
Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: October 08, 2021
LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway.
Journal: Biochemical and biophysical research communications
Published: December 11, 2020
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.
Journal: British journal of cancer
Published: July 06, 2019
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours.
Journal: British journal of cancer
Published: January 24, 2019
Last Updated: 09/26/2026